Abstract
Ultrasound-guided HIFU (USgHIFU) ablation is now a new non-invasive surgical procedure that developed rapidly in China, with vast clinical experience accumulating in treating uterine fibroids, adenomyosis, and other gynecological diseases with great success. However, there were limited collaborative and randomized studies, except those from China. Then the success rate of this new surgery requires more validations. Therefore, to advance this new surgical approach, the paper calls for collaborative validation from reports of large randomized, multi-center studies on treating uterine fibroids, adenomyosis, and other gynecological diseases. Keywords: FUS; HIFU; USgHIFU; uterine fibroids; adenomyosis; validation
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
